We are live on
!
Find out more
DZ Bank Portfolio holdings
AUM
$113B
1-Year Est. Return
36.92%
This Fund
S&P 500
This Quarter
Est. Return
-1.28%
1 Year Est. Return
+36.92%
3 Year Est. Return
+150.91%
5 Year Est. Return
+223.96%
10 Year Est. Return
–
AUM
$70.4B
AUM Growth
+$3.85B
(+5.8%)
Cap. Flow
+$4.62B
Cap. Flow
% of AUM
6.56%
Top 10 Holdings %
Top 10 Hldgs %
34.8%
Holding
1,088
New
69
Increased
276
Reduced
305
Closed
107
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$1.1B |
| 2 |
UnitedHealth
UNH
|
+$936M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$755M |
| 4 |
Oracle
ORCL
|
+$638M |
| 5 |
Humana
HUM
|
+$605M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$566M |
| 2 |
Accenture
ACN
|
+$454M |
| 3 |
PPG Industries
PPG
|
+$430M |
| 4 |
Coca-Cola
KO
|
+$421M |
| 5 |
Advanced Micro Devices
AMD
|
+$413M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.89% |
| 2 | Healthcare | 16.66% |
| 3 | Financials | 10.28% |
| 4 | Consumer Discretionary | 8.89% |
| 5 | Industrials | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
iShare MSCI Eurozone ETF
EZU
$9.64B
| $6.77M | 0.01% |
160,344
-331,853
| -67% | -$14.9M |
|
352
Albertsons Companies
ACI
$5.62B
| $6.66M | 0.01% |
292,832
+48,272
| +20% | +$1.08M |
|
353
Commercial Metals
CMC
$7.6B
| $6.63M | 0.01% |
134,235
+122,872
| +1,081% | +$6.68M |
|
354
Builders FirstSource
BLDR
$7.15B
| $6.55M | 0.01% |
52,615
+41,921
| +392% | +$5.78M |
|
355
MGIC Investment
MTG
$6.16B
| $6.49M | 0.01% |
389,066
-103,937
| -21% | -$1.77M |
|
|
SSU
356
DELISTED
SIGNA Sports United N.V.
SSU
| $6.45M | 0.01% |
23,449,533
| – | – |
|
357
Trex
TREX
$4.51B
| $6.43M | 0.01% |
104,394
-6,745
| -6% | -$463K |
|
358
Eagle Bancorp
EGBN
$846M
| $6.36M | 0.01% |
296,623
+226,466
| +323% | +$5.51M |
|
359
CAE Inc. Common Shares
CAE
$8.3B
| $6.33M | 0.01% |
269,666
| – | – |
|
360
General Mills
GIS
$19.1B
| $6.21M | 0.01% |
97,221
-2,358
| -2% | -$167K |
|
361
InMode
INMD
$870M
| $6.09M | 0.01% |
200,030
| – | – |
|
362
Ryan Specialty Holdings
RYAN
$5.72B
| $6.06M | 0.01% |
125,180
+42,552
| +51% | +$1.97M |
|
363
Ulta Beauty
ULTA
$22B
| $6.04M | 0.01% |
15,123
-9,454
| -38% | -$4.13M |
|
364
Martin Marietta Materials
MLM
$31.5B
| $5.97M | 0.01% |
+14,546
| New | +$6.43M |
|
365
McCormick & Company Non-Voting
MKC
$13.7B
| $5.9M | 0.01% |
78,001
+1
| +0% | +$84 |
|
366
Microchip Technology
MCHP
$40.3B
| $5.87M | 0.01% |
75,178
+9,379
| +14% | +$785K |
|
367
Beazer Homes USA
BZH
$877M
| $5.84M | 0.01% |
+234,555
| New | +$6.77M |
|
368
Evolent Health
EVH
$348M
| $5.81M | 0.01% |
213,543
+62,043
| +41% | +$1.72M |
|
369
AstraZeneca
AZN
$263B
| $5.77M | 0.01% |
42,580
-43,451
| -51% | -$5.93M |
|
370
Frontdoor
FTDR
$5.1B
| $5.49M | 0.01% |
179,312
+9,252
| +5% | +$307K |
|
371
iShares MSCI India ETF
INDA
$6.89B
| $5.45M | 0.01% |
123,218
+44,378
| +56% | +$1.96M |
|
372
Ironwood Pharmaceuticals
IRWD
$696M
| $5.38M | 0.01% |
558,340
-11,281
| -2% | -$111K |
|
373
National Healthcare
NHC
$3.53B
| $5.37M | 0.01% |
83,867
-1,346
| -2% | -$86.2K |
|
374
Otis Worldwide
OTIS
$27.4B
| $5.33M | 0.01% |
66,339
-20,000
| -23% | -$1.71M |
|
|
SVM
375
Silvercorp Metals
SVM
$2.07B
| $5.31M | 0.01% |
2,300,000
| – | – |
|
Similar funds
VAM
DZ Bank's Q3 2023 Portfolio in Review
As of Q3 2023, DZ Bank held 1,088 positions worth $70.4B, up 5.8% from $66.5B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
DZ Bank deployed $4.62B of net new capital in Q3 2023, opening 69 new positions and adding to 276 existing holdings. Its largest new stake was Kenvue: 1,406,267 shares worth $28.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $566M trimmed.
- DZ Bank's largest Q3 2023 buy was Kenvue: 1,406,267 shares worth $28.2M.
- DZ Bank added most to CRH in Q3 2023, an estimated $1.1B increase.
- DZ Bank's biggest Q3 2023 reduction was Edwards Lifesciences, cutting an estimated $566M.
- DZ Bank fully exited Zimmer Biomet in Q3 2023, selling an estimated $52M.
- DZ Bank's ten largest holdings make up 35% of its $70.4B portfolio in Q3 2023.
- DZ Bank opened 69 new positions and closed 107 in Q3 2023.
- DZ Bank's portfolio value rose 5.8% quarter-over-quarter to $70.4B.
Based on DZ Bank's 13F filing for Q3 2023, filed 14 Nov 2023.